These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome. Lee DS; Kim YS; Yoo IeR; Kang YN; Kim SJ; Oh JK; Kim YK; Wang YP; Park JG; Kang JH; Han DH; Ahn MI; Lee KY Lung Cancer; 2013 May; 80(2):172-8. PubMed ID: 23489556 [TBL] [Abstract][Full Text] [Related]
10. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial. Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656 [TBL] [Abstract][Full Text] [Related]
11. Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer. Brooks ED; Sun B; Feng L; Verma V; Zhao L; Gomez DR; Liao Z; Jeter M; O'Reilly M; Welsh JW; Nguyen QN; Erasmus JJ; Eapen G; Ahrar K; Antonoff MB; Hahn SM; Heymach JV; Rice DC; Chang JY JAMA Netw Open; 2018 Aug; 1(4):e181390. PubMed ID: 30646121 [TBL] [Abstract][Full Text] [Related]
12. Use of Stereotactic Ablative Radiotherapy (SABR) in Non-Small Cell Lung Cancer Measuring More Than 5 cm. Tekatli H; van 't Hof S; Nossent EJ; Dahele M; Verbakel WFAR; Slotman BJ; Senan S J Thorac Oncol; 2017 Jun; 12(6):974-982. PubMed ID: 28286243 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases. Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496 [TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy for second pulmonary nodules after operation for an initial lung cancer. Nishiyama K; Kodama K; Teshima T; Tada H Jpn J Clin Oncol; 2015 Oct; 45(10):947-52. PubMed ID: 26238818 [TBL] [Abstract][Full Text] [Related]
15. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. Widder J; Postmus D; Ubbels JF; Wiegman EM; Langendijk JA Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e291-7. PubMed ID: 21640503 [TBL] [Abstract][Full Text] [Related]
16. Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients. Antonoff MB; Correa AM; Sepesi B; Nguyen QN; Walsh GL; Swisher SG; Vaporciyan AA; Mehran RJ; Hofstetter WL; Rice DC J Thorac Cardiovasc Surg; 2017 Aug; 154(2):689-699. PubMed ID: 28495066 [TBL] [Abstract][Full Text] [Related]
17. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Xia T; Li H; Sun Q; Wang Y; Fan N; Yu Y; Li P; Chang JY Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):117-25. PubMed ID: 16765528 [TBL] [Abstract][Full Text] [Related]
18. Repeated stereotactic ablative radiotherapy using CyberKnife for patients with hepatocellular carcinoma. Lo CH; Huang WY; Lin KT; Lin MJ; Lin TP; Jen YM J Gastroenterol Hepatol; 2014 Nov; 29(11):1919-25. PubMed ID: 25041220 [TBL] [Abstract][Full Text] [Related]
19. CyberKnife radiosurgery for stage I lung cancer: results at 36 months. Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973 [TBL] [Abstract][Full Text] [Related]
20. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer]. Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]